1. Home
  2. KNSA vs SONO Comparison

KNSA vs SONO Comparison

Compare KNSA & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • SONO
  • Stock Information
  • Founded
  • KNSA 2015
  • SONO 2002
  • Country
  • KNSA United Kingdom
  • SONO United States
  • Employees
  • KNSA N/A
  • SONO N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • SONO Consumer Electronics/Video Chains
  • Sector
  • KNSA Health Care
  • SONO Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • SONO Nasdaq
  • Market Cap
  • KNSA 1.9B
  • SONO 1.5B
  • IPO Year
  • KNSA 2018
  • SONO 2018
  • Fundamental
  • Price
  • KNSA $33.28
  • SONO $13.18
  • Analyst Decision
  • KNSA Strong Buy
  • SONO Buy
  • Analyst Count
  • KNSA 6
  • SONO 3
  • Target Price
  • KNSA $40.83
  • SONO $13.67
  • AVG Volume (30 Days)
  • KNSA 711.9K
  • SONO 2.5M
  • Earning Date
  • KNSA 07-29-2025
  • SONO 08-06-2025
  • Dividend Yield
  • KNSA N/A
  • SONO N/A
  • EPS Growth
  • KNSA N/A
  • SONO N/A
  • EPS
  • KNSA 0.07
  • SONO N/A
  • Revenue
  • KNSA $529,332,000.00
  • SONO $1,410,756,000.00
  • Revenue This Year
  • KNSA $37.21
  • SONO N/A
  • Revenue Next Year
  • KNSA $6.10
  • SONO $2.53
  • P/E Ratio
  • KNSA $504.35
  • SONO N/A
  • Revenue Growth
  • KNSA 56.18
  • SONO N/A
  • 52 Week Low
  • KNSA $17.82
  • SONO $7.63
  • 52 Week High
  • KNSA $33.98
  • SONO $15.89
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 65.73
  • SONO 72.57
  • Support Level
  • KNSA $31.78
  • SONO $10.11
  • Resistance Level
  • KNSA $33.66
  • SONO $13.41
  • Average True Range (ATR)
  • KNSA 1.26
  • SONO 0.59
  • MACD
  • KNSA 0.24
  • SONO 0.24
  • Stochastic Oscillator
  • KNSA 90.63
  • SONO 93.03

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: